STOCK TITAN
  1. Home
  2. Financials
  3. OTLK
  4. EPS (Diluted)

Outlook Therapeutics, Inc. (OTLK) EPS by Year

OTLK

Outlook Therapeutics, Inc. lost $1.79 per diluted share in fiscal year 2025. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Outlook Therapeutics, Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$1.79
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

OTLK EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
EPS (Diluted)-$1.79-$4.06-$4.72-$0.31+11.4%-$0.35-$0.67N/A-$1.22-$1.80+51.0%-$3.67N/A

OTLK EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
EPS (Diluted)-$0.15-$0.05-$0.38-$0.19-$0.55-$1.50$0.72$0.76-$0.89-$8.01-$0.86-$0.05+16.7%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Outlook Therapeutics, Inc. financials

Frequently Asked Questions

What was Outlook Therapeutics, Inc.'s diluted earnings per share in fiscal year 2025?

Outlook Therapeutics, Inc. lost $1.79 per diluted share in fiscal year 2025.

What was Outlook Therapeutics, Inc.'s diluted earnings per share in the most recent quarter?

Outlook Therapeutics, Inc. (OTLK) reported -$0.15 in diluted earnings per share in Q3 2026.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Outlook Therapeutics, Inc. (OTLK) reported on that line in every period on record.